SI
XRAY icon

Sapience Investments’s Dentsply Sirona XRAY Stock Holding History

Sapience Investments’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.73K Buy
+235
New +$2.93K 0.35% 90

Other funds holding XRAY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Sapience Investments's XRAY Position: Q1 2026 in Review

Sapience Investments opened a new position in Dentsply Sirona (XRAY) in Q1 2026: 235 shares worth $2.73K. The stake represents 0.35% of the portfolio and ranks #90 among its holdings.

382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • Sapience Investments held 235 shares of Dentsply Sirona worth $2.73K as of Q1 2026.
  • Dentsply Sirona was a new Sapience Investments position in Q1 2026.
  • Dentsply Sirona made up 0.35% of Sapience Investments's portfolio in Q1 2026, its #90 holding.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Sapience Investments's 13F filing for Q1 2026, filed 15 May 2026.